Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

74.36
Delayed Data
As of 3:59pm ET
 +2.09 / +2.89%
Today’s Change
55.00
Today|||52-Week Range
133.62
-31.43%
Year-to-Date
No recent news for Incyte Corp.

Today’s Trading

Previous close72.27
Today’s open72.03
Day’s range71.02 - 74.47
Volume881,498
Average volume (3 months)2,077,307
Market cap$13.6B
Dividend yield--
Data as of 3:59pm ET, 05/02/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+612.74%
Earnings growth (next 5 years)+56.00%
Revenue growth (last year)+47.36%
P/E ratio2,132.6
Price/Sales26.95
Price/Book78.81

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+2.22+2.62%
PRGOPerrigo Company PLC-0.56-0.58%
VRXValeant Pharmaceutic...-0.71-2.13%
MDVNMedivation Inc+0.21+0.36%
Data as of 4:02pm ET, 05/02/2016

Financials

Next reporting dateMay 9, 2016
EPS forecast (this quarter)$0.27
Annual revenue (last year)$753.8M
Annual profit (last year)$6.5M
Net profit margin0.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts

Partner Offers

Search for Jobs